Heart Health

This news channel includes content on cardiovascular disease prevention, cardiac risk stratification, diagnosis, screening programs, and management of major risk factors that include diabetes, hypertension, diet, life style, cholesterol, obesity, ethnicity and socio-economic disparities.
 

Thumbnail

Following controversial guideline, another study connects meat consumption to CVD

Another study has surfaced suggesting that meat—both processed and unprocessed—can have deleterious effects on heart health.

Why VA physicians are writing ‘farmacy’ prescriptions for food, not meds

Patients in Massachusetts may soon be receiving “farmacy” prescriptions in lieu of traditional pharmacy scripts.

Thumbnail

Antihypertensive drug amlodipine lowers long-term risk of gout

A large-scale study published in the Journal of Hypertension Jan. 20 suggests the calcium channel blocker amlodipine can lower hypertensive patients’ BP while simultaneously minimizing their long-term risk of developing gout.

Thumbnail

Ornish beats Mediterranean as best heart-healthy diet of 2020

The Mediterranean diet has been eclipsed as the U.S. News & World Report’s best-ranked heart-healthy diet for the first time in a decade, nudged out of the top spot by the popular Ornish diet.

Thumbnail

How 7 North Carolina clinics increased patient use of statins by 349%

A two-year collaboration between the North Carolina chapter of the American College of Cardiology and North Carolina Association of Free and Charitable Clinics was successful in providing thousands of underserved heart patients with free lipid-lowering therapy and clopidogrel.

Thumbnail

The most physically inactive states, ranked

More than 15% of adults in all U.S. states and territories were physically inactive between 2015 and 2018, according to recent data from the CDC, with estimates ranging from 17.3% to 47.7% between regions.

Thumbnail

Transcendental meditation helps prevent LV hypertrophy in hypertensive black patients

Black patients at a heightened risk for heart disease cut their CV mortality risk by 11% in a study that explored the cardiac benefits of the Transcendental Meditation technique.

Thumbnail

Ozempic receives expanded approval from FDA

The FDA has approved Novo Nordisk’s Ozempic—once-weekly semaglutide—for an expanded indication of CV risk reduction in people with type 2 diabetes and established heart disease.